GlassScriptPhysician profile
James M Moss
NPI 1194725291
$3,348.18
in general payments reported to CMS, 2019-2025
20 companies · $34.00 in 2025
The $34.00 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $452 · 2021: $394 · 2022: $491 · 2023: $395 · 2024: $450 · 2025: $34.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.96 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,392.53 | 2019-2024 | Nucala |
| Genentech USA, INC. | $607.74 | 2019-2023 | Xolair |
| Csl Behring | $347.71 | 2024 | Hizentra |
| Teva Pharmaceuticals USA, INC. | $215.04 | 2019-2023 | Cinqair |
| Astrazeneca Pharmaceuticals LP | $187.06 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $98.25 | 2019-2021 | |
| Octapharma USA, INC. | $61.52 | 2022 | |
| Inspire Medical Systems, INC. | $56.76 | 2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $51.99 | 2022 | |
| Genzyme Corporation | $50.77 | 2022-2023 | |
| Grifols USA, LLC | $44.45 | 2021-2022 | |
| Harmony Biosciences LLC | $43.93 | 2020 | |
| Hospira, INC. | $34.76 | 2022-2023 | |
| Amgen INC. | $34.00 | 2025 | |
| Insmed, INC. | $33.90 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.22 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $22.85 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.77 | 2021 | |
| Bio Products Laboratory USA, INC. | $8.53 | 2023 | Gammaplex, Coagadex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.